Nursing CPD Institute

Keeping patients safe from DKA: Perioperative management of patients using Sodium Glucose Co-transporter – 2 inhibitors

CPD Hours: 1
Current as at 31 March 2021
This session will explore macrovascular and microvascular complications, the pathophysiology behind diabetes complications development and the importance of the annual cycle of care.

“Patients at risk of Diabetic Ketoacidosis (DKA) during the perioperative time”

Course Content

Sodium-glucose co-transporter-2 (SGLT-2) inhibitors may place patients at risk of Diabetic Ketoacidosis (DKA) during the perioperative time. We will discuss the position statement Diabetes Australia released in 2020 to assist with the management of this risk.

This presentation discusses how this class of oral hypoglycaemic agents work and the practicalities around their use during the perioperative time.

Learning Outcomes

In this session you will:

  • Understand how Sodium-glucose co-transporters-2 (SGLT2) inhibitors work
  • Explore the guidelines around their use
  • Discuss euglycaemic diabetic ketoacidosis (DKA)
  • Investigate the practicalities around ceasing and restarting SGLT2 inhibitors – Practical tips
The Nursing CPD Institute

Join NCPDI to access this content.

Join Now

Login if you already have an account.